Anita Afzali, MD

Bachelor's Degree: Washington State University Seattle, WA, 2001 (Genetics and Cell Biology)

Medical Degree: University of Washington Seattle, WA, 2006

Internship: University of Washington Seattle, WA, 2008

Fellowship: University of Washington Seattle, WA, 2012 (Gastroenterology)

American Board of Internal Medicine (Gastroenterology) (Certification Date: 11-20-2013 ) - (Recertification Date: to 07-12-2019 )

Gastroenterology

Digestive Diseases

Internal Medicine

Grant: #TAK VDZ-4066 02-27-2025 -02-26-2028 PPD A Real-World Retrospective Study Assessing Medical Charts to evaluate Vedolizumab and Ustekinumab Outcomes for Biologic-naive and Biologic-experienced Crohn's Disease Patients in Canada and the United Role:PI 193692.25 Hold Level:Industry

Grant: #TAK VDZ-4066 02-27-2025 -02-26-2028 PPD A Real-World Retrospective Study Assessing Medical Charts to evaluate Vedolizumab and Ustekinumab Outcomes for Biologic-naive and Biologic-experienced Crohn's Disease Patients in Canada and the United Role:PI 193692.25 Hold Level:Industry

Grant: #C5041047 ENDEAVOUR-UC 04-25-2025 -04-24-2028 Pfizer, Inc. A Multi-Center, Prospective, Non-Interventional Study of Real-World Effectiveness of Etrasimod in Patients with Ulcerative Colitis (ENDEAVOUR-UC), PROTOCOL NUMBER: C5041047 Role:PI 0.00 Active Level:Industry

Grant: #C5041047 ENDEAVOUR-UC 04-25-2025 -04-24-2028 Pfizer, Inc. A Multi-Center, Prospective, Non-Interventional Study of Real-World Effectiveness of Etrasimod in Patients with Ulcerative Colitis (ENDEAVOUR-UC), PROTOCOL NUMBER: C5041047 Role:PI 0.00 Active Level:Industry

Peer Reviewed Publications

Herfarth, Hans H; Afzali, Anita; Fischer, Monika; Hudesman, David; Abdalla, Maisa; McCabe, Robert; Cohen, Benjamin L; Ungaro, Ryan C; Harlan, Will; Hanson, John; Konijeti, Gauree G; Polyak, Steven; Ritter, Timothy; Salzberg, Bruce; Seminerio, Jennifer; English, Emily; Zhang, Xian; Long, Millie D  (2023). Clinical long-term outcomes of patient-reported outcomes in the prospective real-world Tofacitinib Response in Ulcerative Colitis (TOUR) registry: Tofacitinib Response in Ulcerative Colitis (TOUR). Clinical and translational gastroenterologyMore Information

Danese, Silvio; Panaccione, Remo; Feagan, Brian G; Afzali, Anita; Rubin, David T; Sands, Bruce E; Reinisch, Walter; Panés, Julián; Sahoo, Aparna; Terry, Natalie A; Chan, Daphne; Han, Chenglong; Frustaci, Mary Ellen; Yang, Zijiang; Sandborn, William J; Hisamatsu, Tadakazu; Andrews, Jane M; D'Haens, Geert R  (2023). Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial. The lancet. Gastroenterology & hepatologyMore Information

Afzali, Anita; Lukanova, Rina; Hennessy, Fritha; Kakehi, Sumie; Knight, Hannah; Milligan, Gary; Gupte-Singh, Komal  (2023). Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States. Advances in therapy, 40 (10) , 4321-4338More Information

Danese, Silvio; Panaccione, Remo; Abreu, Maria T; Rubin, David T; Ghosh, Subrata; Dignass, Axel; Afzali, Anita; Wolf, Douglas C; Chiorean, Michael V; Vermeire, Severine; Jain, Anjali; Charles, Lorna; Lawlor, Garrett; Osterman, Mark T; Wu, Hsiuanlin; Canavan, James B; Petersen, Ann Katrin; Colombel, Jean-Frederic; Regueiro, Miguel  (2023). Efficacy and safety of approximately 3 years of continuous ozanimod in moderately to severely active ulcerative colitis: interim analysis of the True North open-label extension. Journal of Crohn's & colitisMore Information

Clement, Benjamin; De Felice, Kara; Afzali, Anita  (2023). Indications and safety of newer IBD treatments in the older patient. Current gastroenterology reports, 25 (7) , 160-168More Information

Axelrad, Jordan; Long, Millie; Horst, Sara; Afzali, Anita; Sapir, Tamar; Fajardo, Kristina; De Felice, Kara; Sandler, Robert; Cross, Raymond  (2022). A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols, 11 (12) , e40382More Information

Feagan, Brian G; Schreiber, Stefan; Afzali, Anita; Rieder, Florian; Hyams, Jeffrey; Kollengode, Kanthi; Pearlman, Jared; Son, Vladimir; Marta, Cecilia; Wolf, Douglas C; D'Haens, Geert G  (2022). Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program. Contemporary clinical trials, 122, 106958More Information

Neyazi, Narges; Safi, Najibullah; Afzali, Anita; Kabir, Misha  (2022). Gender barriers are worsening women's access to health care in Afghanistan. Lancet (London, England), 400 (10354) , 731-732More Information

Long, Millie D; Afzali, Anita; Fischer, Monika; Hudesman, David; Abdalla, Maisa; McCabe, Robert; Cohen, Benjamin L; Ungaro, Ryan C; Harlan, Will; Hanson, John; Konijeti, Gauree; Polyak, Steven; Ritter, Timothy; Salzberg, Bruce; Seminerio, Jennifer; English, Emily; Zhang, Xian; Sharma, Puza P; Herfarth, Hans H  (2023). Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting. Inflammatory bowel diseases, 29 (4) , 570-578More Information

Johnson, Amanda M; Barsky, Maria; Ahmed, Waseem; Zullow, Samantha; Galati, Jonathan; Jairath, Vipul; Narula, Neeraj; Peerani, Farhad; Click, Benjamin H; Coburn, Elliot S; Dang, ThucNhi Tran; Gold, Stephanie; Agrawal, Manasi; Garg, Rajat; Aggarwal, Manik; Mohammad, Danah; Halloran, Brendan; Kochhar, Gursimran S; Todorowski, Hannah; Ud Din, Nabeeha Mohy; Izanec, James; Teeple, Amanda; Gasink, Chris; Muser, Erik; Ding, Zhijie; Swaminath, Arun; Lakhani, Komal; Hogan, Dan; Datta, Samit; Ungaro, Ryan C; Boland, Brigid S; Bohm, Matthew; Fischer, Monika; Sagi, Sashidhar; Afzali, Anita; Ullman, Thomas; Lawlor, Garrett; Baumgart, Daniel C; Chang, Shannon; Hudesman, David; Lukin, Dana; Scherl, Ellen J; Colombel, Jean-Frederic; Sands, Bruce E; Siegel, Corey A; Regueiro, Miguel; Sandborn, William J; Bruining, David; Kane, Sunanda; Loftus, Edward V; Dulai, Parambir S  (2023). The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium. The American journal of gastroenterology, 118 (2) , 317-328More Information

Allen, Kenneth D; Kiefer, Miranda K; Butnariu, Madalina; Afzali, Anita  (2022). Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare. Archives of gynecology and obstetrics, 306 (6) , 1929-1937More Information

Dulai, Parambir S; Rai, Victoria; Raffals, Laura E; Lukin, Dana; Hudesman, David; Kochhar, Gursimran S; Damas, Oriana M; Sauk, Jenny S; Levy, Alexander N; Sofia, M Anthony; Tuskey, Anne; Deepak, Parakkal; Yarur, Andres J; Afzali, Anita; Ananthakrishnan, Ashwin N; Cross, Raymond K; Hanauer, Stephen B; Siegel, Corey A  (2022). Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel. The American journal of gastroenterology, 117 (8) , 1288-1295More Information

Sandborn, William J; D'Haens, Geert R; Reinisch, Walter; Panés, Julián; Chan, Daphne; Gonzalez, Susana; Weisel, Kathleen; Germinaro, Matthew; Frustaci, Mary Ellen; Yang, Zijiang; Adedokun, Omoniyi J; Han, Chenglong; Panaccione, Remo; Hisamatsu, Tadakazu; Danese, Silvio; Rubin, David T; Sands, Bruce E; Afzali, Anita; Andrews, Jane M; Feagan, Brian G  (2022). Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology, 162 (6) , 1650-1664.e8More Information

Pusateri, Antoinette; Anaizi, Ahmad; Nemer, Laura; Hinton, Alice; Lara, Luis; Afzali, Anita  (2022). Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recreational Cannabis. Crohn's & colitis 360, 4 (2) , otac015More Information

Rubin, David T; Sninsky, Charles; Siegmund, Britta; Sans, Miquel; Hart, Ailsa; Bressler, Brian; Bouhnik, Yoram; Armuzzi, Alessandro; Afzali, Anita  (2021). International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey. Inflammatory bowel diseases, 27 (12) , 1942-1953More Information

Pusateri, Antoinette; Hatcher, Ashley; Patel, Nisha; Lehman, Joy; Hinton, Alice; Afzali, Anita  (2021). Impact of rapid infliximab infusions on access at a large academic tertiary medical center. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 78 (22) , 2046-2052More Information

Syal, Gaurav; Serrano, Mariastella; Jain, Animesh; Cohen, Benjamin L; Rieder, Florian; Stone, Christian; Abraham, Bincy; Hudesman, David; Malter, Lisa; McCabe, Robert; Holubar, Stefan; Afzali, Anita; Cheifetz, Adam S; Gaidos, Jill K J; Moss, Alan C  (2021). Health Maintenance Consensus for Adults With Inflammatory Bowel Disease. Inflammatory bowel diseases, 27 (10) , 1552-1563More Information

Hemperly, Amy; Dubinsky, Marla C; Yarur, Andres; Afzali, Anita; Hanauer, Stephen; Kugathasan, Subra; Long, Millie D; Rabizadeh, Shervin; Sockolow, Robbyn; Okada, Lauren; Jain, Anjali; Abreu, Maria T; Vande Casteele, Niels  (2021). Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring. Crohn's & colitis 360, 3 (3) , otab035More Information

Balzora, Sophie; Afzali, Anita; Bewtra, Meenakshi  (2021). Social Media-The Next Glass Ceiling?. Gastroenterology, 161 (1) , 373-374More Information

Afzali, Anita; Furtner, Daniel; Melsheimer, Richard; Molloy, Philip J  (2021). The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable. Advances in therapy, 38 (5) , 2077-2093More Information

Pearlstein, Haley; Bricker, Josh; Michel, Hilary K; Afzali, Anita; Donegan, Amy M; Maltz, Ross M; Boyle, Brendan M; Dotson, Jennifer L  (2021). Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. Journal of pediatric gastroenterology and nutrition, 72 (4) , 563-568More Information

Clark-Snustad, Kindra; Butnariu, Madalina; Afzali, Anita  (2020). Women's Health and Ulcerative Colitis. Gastroenterology clinics of North America, 49 (4) , 769-789More Information

Chiorean, Michael; Afzali, Anita; Cross, Raymond K; Macaulay, Dendy; Griffith, Jenny; Wang, Anthony; Garcia-Horton, Viviana  (2020). Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or Vedolizumab. Crohn's & colitis 360, 2 (2) , otaa031More Information

McMahon, Kevin R; Allen, Kenneth D; Afzali, Anita; Husain, Syed  (2020). Predicting Post-operative Complications in Crohn's Disease: an Appraisal of Clinical Scoring Systems and the NSQIP Surgical Risk Calculator. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 24 (1) , 88-97More Information

Menon, Tara; Afzali, Anita  (2019). Immune-Mediated Colitis. Current treatment options in gastroenterology, 17 (4) , 506-523More Information

Alley, Kristen; Singla, Anand; Afzali, Anita  (2019). Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease. Inflammatory bowel diseases, 25 (12) , 1990-1995More Information

Menon, Tara; Afzali, Anita  (2019). Inflammatory Bowel Disease: A Practical Path to Transitioning From Pediatric to Adult Care. The American journal of gastroenterology, 114 (9) , 1432-1440More Information

Sobotka, Lindsay A; Crilley, Tessa; Levine, Edward; Afzali, Anita  (2019). Acute Myelogenous Leukemia as a Rare Cause of Duodenal Ulcers. ACG case reports journal, 6 (7) , e00153More Information

Afzali, Anita  (2019). Inflammatory bowel disease during pregnancy: management of a disease flare or remission. Current opinion in gastroenterology, 35 (4) , 281-287More Information

Kruger, Andrew J; Hinton, Alice; Afzali, Anita  (2019). To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn's Disease Patients. Inflammatory bowel diseases, 25 (7) , e74-e76More Information

Chen, Tong; Shi, Ni; Afzali, Anita  (2019). Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease. Nutrients, 11 (6) More Information

Afzali, Anita  (2019). Update on Pregnancy in Patients With Inflammatory Bowel Disease. Gastroenterology & hepatology, 15 (6) , 313-315

Kruger, Andrew J; Hinton, Alice; Afzali, Anita  (2019). Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients. Inflammatory bowel diseases, 25 (5) , 894-901More Information

Afzali, Anita; Katz, Seymour  (2018). Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD. Current treatment options in gastroenterology, 16 (3) , 289-305More Information

Clowse, Megan E B; Scheuerle, Angela E; Chambers, Christina; Afzali, Anita; Kimball, Alexa B; Cush, John J; Cooney, Maureen; Shaughnessy, Laura; Vanderkelen, Mark; Förger, Frauke  (2018). Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database. Arthritis & rheumatology (Hoboken, N.J.), 70 (9) , 1399-1407More Information

Afzali, Anita; Ciorba, Matthew A; Schwartz, David A; Sharaf, Mai; Fourment, Chris; Ritter, Timothy; Wolf, Douglas C; Shafran, Ira; Randall, Charles W; Kane, Sunanda V  (2017). Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned. Inflammatory bowel diseases, 24 (1) , 2-4More Information

Sandborn, William J; Wolf, Douglas C; Kosutic, Gordana; Parker, Gerry; Schreiber, Stefan; Lee, Scott D; Abraham, Bincy; Afzali, Anita; Arsenescu, Razvan I; Gutierrez, Alexandra; Spearman, Marshall; Coarse, Jason; Feagan, Brian G  (2017). Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's Disease. Inflammatory bowel diseases, 23 (7) , 1047-1056More Information

Afzali, Anita; Wahbeh, Ghassan  (2017). Transition of pediatric to adult care in inflammatory bowel disease: Is it as easy as 1, 2, 3?. World journal of gastroenterology, 23 (20) , 3624-3631More Information

Afzali, Anita; Ogden, Kristine; Friedman, Michael L; Chao, Jingdong; Wang, Anthony  (2017). Costs of providing infusion therapy for patients with inflammatory bowel disease in a hospital-based infusion center setting. Journal of medical economics, 20 (4) , 409-422More Information

Afzali, Anita; Sinanan, Mika N; Lee, Scott D  (2017). Reply. Inflammatory bowel diseases, 23 (1) , E3More Information

Afzali, Anita; Cross, Raymond K  (2016). Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences. Inflammatory bowel diseases, 22 (8) , 2023-40More Information

Afzali, Anita; Park, Christopher J; Zhu, Kehao; Hu, Jie Kate; Sharma, Prachi; Sinanan, Mika N; Lee, Scott D  (2016). Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases, 22 (8) , 1887-95More Information

Fausel, Rebecca; Afzali, Anita  (2015). Biologics in the management of ulcerative colitis - comparative safety and efficacy of TNF-α antagonists. Therapeutics and clinical risk management, 11, 63-73More Information

Kelly, Colleen R; Ihunnah, Chioma; Fischer, Monika; Khoruts, Alexander; Surawicz, Christina; Afzali, Anita; Aroniadis, Olga; Barto, Amy; Borody, Thomas; Giovanelli, Andrea; Gordon, Shelley; Gluck, Michael; Hohmann, Elizabeth L; Kao, Dina; Kao, John Y; McQuillen, Daniel P; Mellow, Mark; Rank, Kevin M; Rao, Krishna; Ray, Arnab; Schwartz, Margot A; Singh, Namita; Stollman, Neil; Suskind, David L; Vindigni, Stephen M; Youngster, Ilan; Brandt, Lawrence  (2014). Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. The American journal of gastroenterology, 109 (7) , 1065-71More Information

Afzali, Anita; Wheat, Chelle L; Hu, Jie Kate; Olerud, John E; Lee, Scott D  (2014). The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series. Journal of Crohn's & colitis, 8 (6) , 480-8More Information

Wolf, Douglas C; Abraham, Bincy P; Afzali, Anita; Allegretti, Paul D; Arai, Ronen  (2012). Community Perspectives: Combining Serology, Genetics, and Inflammation Markers for the Diagnosis of IBD and Differentiation Between CD and UC. Gastroenterology & hepatology, 8 (6 Suppl 2) , 1-16

Afzali, Anita; Berry, Kristin; Ioannou, George N  (2012). Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 18 (1) , 29-37More Information

Afzali, Anita; Weiss, Noel S; Boyko, Edward J; Ioannou, George N  (2010). Association between serum uric acid level and chronic liver disease in the United States. Hepatology (Baltimore, Md.), 52 (2) , 578-89More Information

Afzali A.; Carlson C.; Lee S.; Wheat C.  (06-01-2012). 31-Year-old male with frequent bleeding and portal vein thrombosis. Gastroenterology and Hepatology, 8 (6) , 8-10

Afzali A.; Carlson C.; Lee S.; Wheat C.  (06-01-2012). 31-Year-old male with frequent bleeding and portal vein thrombosis. Gastroenterology and Hepatology, 8 (6) , 8-10

Fausel R.; Afzali A.; Afzali A.  (01-01-2015). Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-? antagon. Therapeutics and Clinical Risk Management, 11, 63-72

Fausel R.; Afzali A.; Afzali A.  (01-01-2015). Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-? antagon. Therapeutics and Clinical Risk Management, 11, 63-72

Afzali A.; Wheat C.L.; Lee S.D.  (01-01-2014). Oral and parenteral corticosteroid therapy in ulcerative colitis. Medical Therapy of Ulcerative Colitis, 111-120More Information

Afzali A.; Wheat C.L.; Lee S.D.  (01-01-2014). Oral and parenteral corticosteroid therapy in ulcerative colitis. Medical Therapy of Ulcerative Colitis, 111-120More Information

Tiderington E.; Afzali Md A.  (05-01-2018). A practical approach to management of the patient with inflammatory bowel disease following tumor ne. Journal of Clinical Outcomes Management, 25 (5)

Tiderington E.; Afzali Md A.  (05-01-2018). A practical approach to management of the patient with inflammatory bowel disease following tumor ne. Journal of Clinical Outcomes Management, 25 (5)

O’Malley R.B.; Hansen N.J.; Carnell J.; Afzali A.; Moshiri M.  (08-01-2016). Update on MR Enterography: Potentials and Pitfalls. Current Radiology Reports, 4 (8) More Information

O’Malley R.B.; Hansen N.J.; Carnell J.; Afzali A.; Moshiri M.  (08-01-2016). Update on MR Enterography: Potentials and Pitfalls. Current Radiology Reports, 4 (8) More Information

Afzali A.  (01-01-2019). Update on pregnancy in patients with inflammatory bowel disease. Gastroenterology and Hepatology, 15 (6) , 313-315

Afzali A.  (01-01-2019). Update on pregnancy in patients with inflammatory bowel disease. Gastroenterology and Hepatology, 15 (6) , 313-315

Chiorean M.; Afzali A.; Cross R.K.; Macaulay D.; Griffith J.; Wang A.; Garcia-Horton V.  (04-01-2020). Economic outcomes of inflammatory bowel disease patients switching to a second anti-tumor necrosis f. Crohn's and Colitis 360, 2 (2) More Information

Hemperly A.; Dubinsky M.C.; Yarur A.; Afzali A.; Hanauer S.; Kugathasan S.; Long M.D.; Rabizadeh S.; Sockolow R.; Okada L.; Jain A.; Abreu M.T.; Vande Casteele N.  (07-01-2021). Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic . Crohn's and Colitis 360, 3 (3) , 1-8More Information

Sands B.E.; Irving P.M.; Hoops T.; Izanec J.L.; Gao L.L.; Gasink C.; Greenspan A.; Allez M.; Danese S.; Hanauer S.B.; Jairath V.; Kuehbacher T.; Lewis J.D.; Loftus E.V.; Mihaly E.; Mihaly E.; Panaccione R.; Scherl E.; Shchukina O.B.; Sandborn W.J.; Afzali A.; Aitova L.; Aldeguer i Mante X.; Altorjay I.; Argüelles Arias F.; Armuzzi A.; Augustyn M.; Bafutto M.; Barrio J.; Begun J.; Behrend C.; Bezemer G.; Bonnaud G.; Brankovic M.; Byung I.J.; Calvet Calvo X.; Chachu K.; Chebli J.M.F.; Cheon J.H.; Cichoz-Lach H.; Clark L.; Cummings F.; Dalal K.; De Boer N.; De Lourdes Ferrari M.; Désilets E.; Dugalic P.; Duvall G.; Fedorishina O.; Filip R.; Flores C.; Fogel R.; Fon J.; Frankel M.; Friedenberg K.; Fries W.; Galina V.; Gietka P.; Goel R.; Hasselblatt P.; Herfarth H.; Herszényi L.; Hindryckx P.; Hoentjen F.; Horjus Talabur Horje C.; Iduru S.; Isfort R.; Jones M.; Kalimullina D.; Katz J.; Kaur M.; Khurana S.K.; Kim J.S.; Kim Y.; Kleczkowski D.; Knezevic S.; Knoll A.; Korman L.Y.; Kotzev I.; Kulyapin A.; Lee K.M.; Leemreis D.; Leszczyszyn J.; Limdi J.; Lissauer J.; Loftus E.; Malecka-Panas E.; Marshall J.; Milan L.; Monteleone G.; Nagorni A.; Owczarek D.; Palekar N.; Park Y.S.; Park S.H.; Parra R.; Patai Á.; Patel K.; Patel B.; Pershko A.  (06-11-2022). Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with . The Lancet, 399 (10342) , 2200-2211More Information

Pusateri A.; Anaizi A.; Nemer L.; Hinton A.; Lara L.; Afzali A.  (04-01-2022). Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recre. Crohn's and Colitis 360, 4 (2) More Information

Axelrad J.; Long M.; Horst S.; Afzali A.; Sapir T.; Fajardo K.; De Felice K.; Sandler R.; Cross R.  (12-01-2022). A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With . JMIR Research Protocols, 11 (12) More Information

Danese S.; Panaccione R.; Feagan B.G.; Afzali A.; Rubin D.T.; Sands B.E.; Reinisch W.; Panés J.; Sahoo A.; Terry N.A.; Chan D.; Han C.; Frustaci M.E.; Yang Z.; Sandborn W.J.; Hisamatsu T.; Andrews J.M.; D'Haens G.R.; Oliinyk O.; Bilianskyi L.; Gniady-Jastrzebska J.; Petryka R.; Arlukowicz T.; Gietka P.; Zmudzinski M.; Mumtaz S.; Wolf D.; Wojcik K.; Duvall G.; Augustyn M.; Filip R.; Tarabar D.; Tkachev A.; Seidler U.; Zittan E.; Pokrotnieks J.; Shchukina O.; Machavariani A.; Loy L.; Abu-farsakh N.; Marina P.; Sreckovic S.; Laclav M.; Wei S.C.; Suiter D.; Borsuk A.; Hebuterne X.; Buning C.; Lahat-Zok A.; Danilkiewicz W.; Frysna B.; Jovicic I.; Datsenko O.; Guram M.; Jain A.; Rashid Z.; Heeren S.; Shulga N.; Timkin I.; Gornjakovic S.; Lukas M.; Altwegg R.; Desjeux A.; Reimund J.M.; Giorgadze M.; Jochum C.; Ito H.; Nakai K.; Takagi T.; Zaha O.; Choi C.; Kim T.; Lee J.; Stundiene I.; Hilmi I.N.; Hj Md Said R.; Leszczyszyn J.; Abdulganieva D.; Fominykh Y.; Maksyashina S.; Balaz J.; Van Domselaar M.; Kav T.; Dennis P.; Henry P.; Holmes R.; Johnson C.; McBride M.; Sarles H.; Moore G.; Yakubtsevich R.; Muls V.; Trbojevic S.; Afif W.; Bernstein C.; Klarin I.; Serclova Z.; Volfova M.; Desreumaux P.; Gilletta de Saint Joseph C.  (01-01-2023). Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results. The Lancet Gastroenterology and HepatologyMore Information

Academic - MSB
231 Albert Sabin Way
Cincinnati  Ohio, 45267